Each episode of All Things Cancer spotlights a pressing topic in oncology, from cutting-edge treatments and emerging research to personal stories of resilience and hope. More than just a podcast, it’s a platform for raising awareness, advancing cancer education, and fostering a global community of support and collaboration.
Check Out The Latest Episode of the All Things Cancer Podcast:
#11
Rethinking Cancer: A Conversation with Dr. Isaac Witz
In his discussion with NFCR CEO Dr. Sujuan Ba, Dr. Isaac Witz, the 2023 winner of the Szent-Györgyi Prize for Progress in Cancer Research, emphasizes the importance of keeping patients at the heart of research. He explains that therapies cannot simply aim to destroy tumors — they must also consider how the body’s own systems sometimes help cancer survive and spread.
#10
Harnessing the Immune System with Drew Pardoll
Discover how Dr. Drew Pardoll’s pioneering journey in cancer immunology is shaping the future of treatment. In this All Things Cancer episode, he shares the breakthroughs, mentorship, and vision driving progress against cancer.
#9
Cheryl’s Journey Through Stage 4 Melanoma
In this episode, Dr. Sujuan Ba interviews Cheryl, a stage IV melanoma survivor whose persistence and optimism helped her beat the odds. Initially told there were no treatment options and that she might not survive past the holidays, Cheryl refused to accept that outcome.
#8
Early Detection and Intervention: the New Era in Cancer Prevention
This episode focuses on early detection and early intervention in cancer. A consistent theme from every expert is that detecting cancer early only matters if it’s paired with actionable treatment. Early detection without therapy just creates anxiety, so advances in testing need to move in lockstep with targeted treatments.
#7
Hope Stewart on Facing Cancer and Giving Back
In the debut episode of our Survivor Stories mini-series, breast cancer survivor and NFCR Community Ambassador Hope Stewart shares her emotional journey, the support that got her through, and the research that saved her life.
#6
When the Money Stops: What’s at Risk in Cancer Research
In this episode of All Things Cancer, NFCR CEO Dr. Sujuan Ba speaks with leading researchers about the funding crisis threatening cancer research across the U.S. and beyond. From early-stage, high-risk studies to game-changing therapies now approaching clinical trials, these conversations reveal what’s possible when bold science is backed by strong support—and what’s lost when it isn’t.
#5
FEATURING: Dr. Rakesh K. Jain, Massachusetts General Hospital and Harvard Medical School
In this special edition of All Things Cancer, Dr. Rakesh K. Jain and Dr. Sujuan Ba discuss the longstanding partnership between the National Foundation for Cancer Research (NFCR) and Dr. Jain. They highlight the significant impact of NFCR’s early-stage funding model, which supports researchers in transforming promising ideas from the laboratory into clinical development.
#4
FEATURING: Dr. James P. Allison, MD Anderson
Nobel Laureate Dr. James Allison reflects on what first sparked his interest in T cells, the resistance he faced from the research and pharmaceutical communities, and the long journey from discovery to clinical success. He also discusses the importance of supporting early-stage research and the future of integrated cancer therapy.
#3
FEATURING: Dr. Dennis Slamon, UCLA Health
Dr. Dennis Slamon, recipient of the 2024 Szent-Györgyi Prize for Progress in Cancer Research, joins us on our latest episode of the All Things Cancer podcast to discuss his groundbreaking work in cancer research, particularly his role in developing the drug Herceptin (trastuzumab).
#2
FEATURING: Dr. Azra Raza, Columbia University
Dr. Azra Raza is a renowned oncologist, researcher, and author of The First Cell. In this episode, Dr. Raza shares her groundbreaking research, the urgent need for a paradigm shift in cancer treatment, and how we can move toward real change.
#1
FEATURING: Dr. Margaret Foti, American Association for Cancer Research
Dr. Maragaret Foti serves as CEO of the American Association for Cancer Research and was awarded the 2024 AIM-HI Beacon Award for Women Leaders in Oncology. In this first episode, Dr. Foti shares her extensive expertise in advancing cancer research, the challenges and opportunities in the field today, and why collaboration is crucial for accelerating progress toward cures.
